Year : 2017 | Volume
: 6 | Issue : 2 | Page : 445--446
Candidate for a live vaccine?
Justin Ralph Abbatemarco1, Alan Taege2
1 Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
2 Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio, USA
Immune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated. Live vaccinations are selected cautiously but the varicella-zoster virus (VZV) vaccine, Zostavax, is recommended for pretransplant candidates. This case highlights an ESLD patient who developed disseminated cutaneous VZV within 30 days of vaccination.
Dr. Justin Ralph Abbatemarco
Cleveland Clinic, 9500 Euclid Ave S100A, Cleveland, OH 44195
|How to cite this article:|
Abbatemarco JR, Taege A. Candidate for a live vaccine?.J Family Med Prim Care 2017;6:445-446
|How to cite this URL:|
Abbatemarco JR, Taege A. Candidate for a live vaccine?. J Family Med Prim Care [serial online] 2017 [cited 2021 May 18 ];6:445-446
Available from: https://www.jfmpc.com/article.asp?issn=2249-4863;year=2017;volume=6;issue=2;spage=445;epage=446;aulast=Abbatemarco;type=0